BI signs deal with MiNA to develop liver disease drugs

9th November 2017 Uncategorised 0

Boehringer Ingelheim has signed a second deal focused on the development of RNA therapeutics for liver diseases.

More: BI signs deal with MiNA to develop liver disease drugs
Source: News